Submitted by web@researchtop... on Fri, 01/07/2011 - 11:56
Slides from presentations at ASH 2010 and transcribed comments from a recent interview with Rafael Fonseca, MD (12/22/10)
Attal M et al. Maintenance treatment with lenalidomide after transplantation for MYELOMA: Final analysis of the IFM 2005-02. Proc ASH 2010;Abstract 310.
Palumbo A et al. A Phase 3 study evaluating the efficacy and safety of lenalidomide combined with melphalan and prednisone in patients ≥ 65 years with newly diagnosed multiple myeloma (NDMM): Continuous use of lenalidomide vs fixed-duration regimens. Proc ASH 2010;Abstract 622.
Dr Fonseca is Professor of Medicine at the Mayo Clinic Arizona and Deputy Director of the Mayo Clinic Cancer Center in Scottsdale, Arizona.
